BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15710918)

  • 1. Ovarian cancer screening.
    Eason EL
    CMAJ; 2005 Feb; 172(4):447. PubMed ID: 15710918
    [No Abstract]   [Full Text] [Related]  

  • 2. A doctor talks about. Screening for ovarian cancer.
    Robb-Nicholson C
    Harv Womens Health Watch; 2004 Sep; 12(1):5. PubMed ID: 15381472
    [No Abstract]   [Full Text] [Related]  

  • 3. Ovarian cancer: real progress in early detection.
    Johns Hopkins Med Lett Health After 50; 2005 Jan; 16(11):3, 7. PubMed ID: 15693151
    [No Abstract]   [Full Text] [Related]  

  • 4. By the way, doctor. I received a widely circulated e-mail message about use of the CA-125 blood test in screening for ovarian cancer. The message suggested that the CA-125 test be used for routine screening, like a Pap smear. Do you agree? What's your opinion of this test?
    Robb-Nicholson C
    Harv Womens Health Watch; 2001 Jul; 8(11):8. PubMed ID: 11511469
    [No Abstract]   [Full Text] [Related]  

  • 5. CA 125: Value or addiction?
    Goldman PA
    Cancer; 2010 Jun; 116(12):2854-5. PubMed ID: 20564391
    [No Abstract]   [Full Text] [Related]  

  • 6. My friend says I should get a CA 125 test to check for ovarian cancer. Should I have this test done?
    Mayo Clin Womens Healthsource; 2007 Sep; 11(9):8. PubMed ID: 17700510
    [No Abstract]   [Full Text] [Related]  

  • 7. CA-125 and early ovarian cancer: does this help the clinician or further muddy the water?
    McGuire WP
    J Clin Oncol; 2005 Sep; 23(25):5862-4. PubMed ID: 16087955
    [No Abstract]   [Full Text] [Related]  

  • 8. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer screening and peritoneal carcinomatosis: standards, 'omics' and miRNAs for personalized management.
    Spiliotis J; Halkia E; Roukos DH
    Expert Rev Mol Diagn; 2011 Jun; 11(5):465-7. PubMed ID: 21707454
    [No Abstract]   [Full Text] [Related]  

  • 10. Preoperative serum CA125 in surgical stage 1 epithelial ovarian cancer.
    Obermair A
    Gynecol Oncol; 2007 Nov; 107(2):357-8. PubMed ID: 17706272
    [No Abstract]   [Full Text] [Related]  

  • 11. Should you be screened for ovarian cancer?
    Johns Hopkins Med Lett Health After 50; 2001 May; 13(3):3. PubMed ID: 14727590
    [No Abstract]   [Full Text] [Related]  

  • 12. The myth of measurable disease in ovarian cancer: revisited.
    Markman M
    Cancer Invest; 2009 Jan; 27(1):11-2. PubMed ID: 19160094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACR Appropriateness Criteria on staging and follow-up of ovarian cancer.
    Javitt MC
    J Am Coll Radiol; 2007 Sep; 4(9):586-9. PubMed ID: 17845961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of serum biomarkers for detection of early-stage ovarian cancer.
    Nosov V; Su F; Amneus M; Birrer M; Robins T; Kotlerman J; Reddy S; Farias-Eisner R
    Am J Obstet Gynecol; 2009 Jun; 200(6):639.e1-5. PubMed ID: 19285648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the risk of ovarian cancer.
    Ebell MH
    Am Fam Physician; 2009 Sep; 80(6):632-4. PubMed ID: 19817330
    [No Abstract]   [Full Text] [Related]  

  • 16. The quest for ovarian cancer's Holy Grail: can CA-125 still be the chalice of early detection?
    Karlan BY; McIntosh M
    J Clin Oncol; 2007 Apr; 25(11):1303-4. PubMed ID: 17416848
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer.
    Hermsen BB; von Mensdorff-Pouilly S; Berkhof J; van Diest PJ; Gille JJ; Menko FH; Blankenstein MA; Kenemans P; Verheijen RH
    J Clin Oncol; 2007 Apr; 25(11):1383-9. PubMed ID: 17416858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CA-125 as a biomarker for malignant transformation of endometriosis.
    Check JH
    Fertil Steril; 2009 May; 91(5):e35; author reply e36. PubMed ID: 19338996
    [No Abstract]   [Full Text] [Related]  

  • 19. Spontaneous uroperitoneum and elevated Ca-125.
    Li YX; Vaux K; Coleman P
    Eur J Intern Med; 2008 Nov; 19(7):e47-8. PubMed ID: 19013362
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical problem-solving: hypereosinophilic syndrome.
    Hassell LA
    N Engl J Med; 1996 Feb; 334(8):539; author reply 540. PubMed ID: 8559221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.